(Total Views: 675)
Posted On: 12/31/2020 12:06:13 AM
Post# of 145879
![](/m/assets/46931549/no_avatar_available_thumb.jpg)
FDA Accepts Protocol for Adding an Open-Label Extension to CytoDyn’s Phase 3 Trial for Severe-to-Critical COVID-19 Patients
https://www.cytodyn.com/newsroom/press-releas...tension-to
https://www.cytodyn.com/newsroom/press-releas...tension-to
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)